VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AURA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AURAAura Biosciences, Inc.
$7.03$451M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAURAQuarterly Financials

Aura Biosciences, Inc. (AURA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Aura Biosciences, Inc. (AURA) quarterly income statement — complete revenue, gross profit & net income history

AURA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold274K00300K0291K00306K324K0000000000
COGS % of Revenue--------------------
Gross Profit-274K00-300K0-291K00-306K-324K0000000000
Gross Margin %--------------------
Gross Profit Growth %-100%--100%10.19%--------------
Operating Expenses34.59M27.24M27.91M28.31M29.04M27.52M23.23M22.76M22.01M24.46M20.49M20.28M19.44M17.61M16.05M13.82M12.81M11.63M8.89M8.8M
OpEx % of Revenue--------------------
Selling, General & Admin6.91M5.34M5.73M5.73M5.69M5.18M6.2M5.88M4.96M4.18M5.06M5.16M5.04M4.45M4.76M4.31M4.54M3.65M2.53M2.17M
SG&A % of Revenue--------------------
Research & Development27.96M21.9M22.18M22.88M23.34M22.33M17.04M16.88M17.05M20.28M15.43M15.12M14.4M13.16M11.29M9.51M8.28M7.98M6.37M6.63M
R&D % of Revenue--------------------
Other Operating Expenses-274K00-300K0000000000000000
Operating Income-34.87M-27.24M-27.91M-28.61M-29.04M-27.81M-23.23M-22.76M-22.31M-24.78M-20.49M-20.28M-19.44M-17.61M-16.05M-13.82M-12.81M-11.63M-8.89M-8.8M
Operating Margin %--------------------
Operating Income Growth %-20.08%2.05%-20.12%-25.71%-30.13%-12.2%-13.39%-12.26%-14.76%-40.71%-27.61%-46.76%-51.78%-51.48%-80.49%-56.98%-116.15%-136.85%--
EBITDA-34.59M-26.96M-27.63M-28.31M-28.74M-27.52M-22.92M-22.45M-22.01M-24.46M-20.14M-19.98M-19.12M-17.29M-15.75M-13.52M-12.55M-11.4M-8.68M-8.6M
EBITDA Margin %--------------------
EBITDA Growth %-20.35%2%-20.54%-26.12%-30.61%-12.5%-13.77%-12.38%-15.12%-41.46%-27.88%-47.75%-52.26%-51.71%-81.51%-57.19%-118.65%-143.37%--
D&A (Non-Cash Add-back)274K272K280K300K291K291K313K313K306K324K343K300K328K323K302K296K256K230K216K200K
EBIT-34.87M-27.24M-27.91M-26.97M-29.04M-25.81M-23.23M-22.76M-22.31M-21.99M-20.49M-20.28M-19.44M-17.61M-16.05M-13.82M-12.81M-11.63M-8.89M-8.8M
Net Interest Income1.19M1.54M1.81M1.68M1.59M2.03M2.26M2.45M2.69M2.61M1.98M2.01M1.99M1.06M483K292K25K5K5K4K
Interest Income1.19M1.54M1.81M1.68M1.59M2.03M2.26M2.45M2.69M2.61M1.98M2.01M1.99M1.06M483K292K25K5K5K4K
Interest Expense0000000000000000000-
Other Income/Expense1.19M1.69M1.8M1.64M1.57M2M2.23M2.42M2.65M2.79M1.98M1.98M1.98M1.05M154K348K-24K-7K57K-51K
Pretax Income-33.67M-25.54M-26.1M-26.97M-27.46M-25.81M-21M-20.34M-19.66M-21.99M-18.51M-18.3M-17.47M-16.56M-15.9M-13.47M-12.84M-11.63M-8.84M-8.85M
Pretax Margin %--------------------
Income Tax11K15K26K48K18K24K43K046K137K0000000000
Effective Tax Rate %-0.03%-0.06%-0.1%-0.18%-0.07%-0.09%-0.2%0%-0.23%-0.62%0%0%0%0%0%0%0%0%0%0%
Net Income-33.69M-25.56M-26.13M-27.02M-27.48M-25.83M-21.04M-20.34M-19.71M-22.13M-18.51M-18.3M-17.47M-16.56M-15.9M-13.47M-12.84M-11.63M-8.84M-8.85M
Net Margin %--------------------
Net Income Growth %-22.57%1.06%-24.18%-32.86%-39.47%-16.73%-13.67%-11.14%-12.82%-33.65%-16.42%-35.87%-36.08%-42.33%-79.92%-52.15%-116.55%-137.09%--
Net Income (Continuing)-33.69M-25.56M-26.13M-27.02M-27.48M-25.83M-21.04M-20.34M-19.71M-22.13M-18.51M-18.3M-17.47M-16.56M-15.9M-13.47M-12.84M-11.63M-8.84M-8.85M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.50-0.40-0.40-0.47-0.55-0.52-0.42-0.41-0.40-0.50-0.48-0.48-0.40-1.31-0.54-0.46-0.44-0.42-0.32-0.45
EPS Growth %9.09%23.08%4.76%-14.63%-37.5%-4%12.5%14.58%0%61.83%11.11%-4.35%9.09%-211.9%-68.75%-2.22%-46.67%-68%--
EPS (Basic)-0.50-0.40-0.40-0.47-0.55-0.52-0.42-0.41-0.40-0.50-0.48-0.48-0.40-1.31-0.54-0.46-0.44-0.42-0.32-0.45
Diluted Shares Outstanding67.45M60.34M65.94M58.02M50.13M49.65M49.66M49.55M49.45M44.44M38.19M37.86M37.78M31.85M29.27M29.25M29.21M28.01M28.01M19.57M
Basic Shares Outstanding67.45M60.34M65.94M58.02M50.13M49.65M49.66M49.55M49.45M44.44M38.19M37.86M37.78M31.85M29.27M29.25M29.21M28.01M28.01M19.57M
Dividend Payout Ratio--------------------